We are live on ! Find out more
Handelsbanken Fonder

Handelsbanken Fonder Portfolio holdings

AUM $35.1B
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
+13.09%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$23.2B
AUM Growth
+$2.65B
Cap. Flow
+$745M
Cap. Flow %
3.21%
Top 10 Hldgs %
28.76%
Holding
1,586
New
30
Increased
559
Reduced
189
Closed
24

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$113M
2
AAPL icon
Apple
AAPL
+$86.8M
3
MSFT icon
Microsoft
MSFT
+$69.1M
4
BKNG icon
Booking.com
BKNG
+$67.4M
5
AMZN icon
Amazon
AMZN
+$66.2M

Top Sells

Rank Stock Value
1
DAR icon
Darling Ingredients
DAR
+$109M
2
PCTY icon
Paylocity
PCTY
+$41.6M
3
ON icon
ON Semiconductor
ON
+$40.9M
4
ALB icon
Albemarle
ALB
+$35.3M
5
LLY icon
Eli Lilly
LLY
+$29.6M

Sector Composition

Rank Sector Weight
1 Technology 33.48%
2 Healthcare 19.41%
3 Financials 10.89%
4 Industrials 10.11%
5 Consumer Discretionary 8.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRGS icon
1251
Progress Software
PRGS
$1.77B
$411K ﹤0.01%
7,716
CRTO icon
1252
Criteo S.A. Ordinary Shares
CRTO
$890M
$410K ﹤0.01%
11,700
TDOC icon
1253
Teladoc Health
TDOC
$1.25B
$409K ﹤0.01%
27,100
ABR icon
1254
Arbor Realty Trust
ABR
$979M
$408K ﹤0.01%
30,800
AMBA icon
1255
Ambarella
AMBA
$3.62B
$408K ﹤0.01%
8,044
ATRC icon
1256
AtriCure
ATRC
$2.21B
$408K ﹤0.01%
13,400
RCM
1257
DELISTED
R1 RCM Inc. Common Stock
RCM
$407K ﹤0.01%
31,600
NUVL
1258
DELISTED
Nuvalent
NUVL
$405K ﹤0.01%
5,400
PJT icon
1259
PJT Partners
PJT
$4.4B
$405K ﹤0.01%
4,300
MORF
1260
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$405K ﹤0.01%
11,500
+2,100
+22% +$70.4K
CNS icon
1261
Cohen & Steers
CNS
$4.35B
$404K ﹤0.01%
5,251
IVT icon
1262
InvenTrust Properties
IVT
$2.6B
$404K ﹤0.01%
15,700
PPBI
1263
DELISTED
Pacific Premier Bancorp
PPBI
$404K ﹤0.01%
16,823
CPRX
1264
DELISTED
Catalyst Pharmaceutical
CPRX
$403K ﹤0.01%
25,277
PRK icon
1265
Park National Corp
PRK
$3.75B
$403K ﹤0.01%
2,965
TRS icon
1266
TriMas Corp
TRS
$1.4B
$403K ﹤0.01%
15,095
ENVA icon
1267
Enova International
ENVA
$6.55B
$402K ﹤0.01%
6,400
+2,500
+64% +$146K
NMRK icon
1268
Newmark Group
NMRK
$2.73B
$402K ﹤0.01%
36,217
STAA icon
1269
STAAR Surgical
STAA
$1.25B
$402K ﹤0.01%
10,500
UPST icon
1270
Upstart Holdings
UPST
$2.91B
$401K ﹤0.01%
14,900
+2,900
+24% +$85.8K
PRFT
1271
DELISTED
Perficient Inc
PRFT
$400K ﹤0.01%
7,112
+1,700
+31% +$111K
LZB icon
1272
La-Z-Boy
LZB
$1.67B
$399K ﹤0.01%
10,602
CSTM icon
1273
Constellium
CSTM
$3.97B
$398K ﹤0.01%
18,000
EBC icon
1274
Eastern Bankshares
EBC
$5.37B
$398K ﹤0.01%
28,900
CHWY icon
1275
Chewy
CHWY
$9.05B
$396K ﹤0.01%
24,900

Similar funds

Handelsbanken Fonder's Q1 2024 Portfolio in Review

As of Q1 2024, Handelsbanken Fonder held 1,586 positions worth $23.2B, up 13% from $20.6B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Handelsbanken Fonder deployed $745M of net new capital in Q1 2024, opening 30 new positions and adding to 559 existing holdings. Its largest new stake was Arcadium Lithium plc: 4,193,903 shares worth $18.1M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Darling Ingredients, an estimated $109M trimmed.

  • Handelsbanken Fonder's largest Q1 2024 buy was Arcadium Lithium plc: 4,193,903 shares worth $18.1M.
  • Handelsbanken Fonder added most to Meta Platforms (Facebook) in Q1 2024, an estimated $113M increase.
  • Handelsbanken Fonder's biggest Q1 2024 reduction was Darling Ingredients, cutting an estimated $109M.
  • Handelsbanken Fonder fully exited Splunk Inc in Q1 2024, selling an estimated $13.1M.
  • Handelsbanken Fonder's ten largest holdings make up 29% of its $23.2B portfolio in Q1 2024.
  • Handelsbanken Fonder opened 30 new positions and closed 24 in Q1 2024.
  • Handelsbanken Fonder's portfolio value rose 13% quarter-over-quarter to $23.2B.

Based on Handelsbanken Fonder's 13F filing for Q1 2024, filed 13 May 2024.